Cross-linked hyaluronic acid/dextranomer
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cross-linked hyaluronic acid/dextranomer, covering 2024-09-26 to 2024-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Cross-linked Hyaluronic Acid/dextranomer for the Treatment of Stress Urinary Incontinence [Phase 2]